Child developmental outcomes in preschool children following antidepressant exposure in pregnancy

Megan Galbally1, Andrew J Lewis2, Anne Buist3

  • 1Perinatal Mental Health, Mercy Hospital for Women, Heidelberg, Australia Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, Australia mgalbally@mercy.com.au.

Insights

Antidepressant exposure during pregnancy showed no significant impact on preschool children's cognition or behavior. However, a slight trend towards lower motor development was observed, warranting further research.

Area of Science:

  • Developmental psychology
  • Neuroscience
  • Pharmacology

Background:

  • Prenatal exposure to antidepressant medication is a growing concern.
  • Understanding the long-term effects on child development is crucial for clinical practice.

Purpose of the Study:

  • To investigate child developmental outcomes at age 4 in children exposed to antidepressants during pregnancy.
  • To compare these outcomes with a cohort of unexposed children.

Main Methods:

  • A prospective case-controlled study involving 20 children exposed to antidepressants and 21 unexposed controls.
  • Assessment of cognitive, motor, and behavioral development using standardized tests (WPPSI-III, MABC, BRIEF-P, CBCL).
  • Maternal depression levels were monitored throughout pregnancy and early childhood.

Main Results:

  • No statistically significant differences were found in cognitive or behavioral development between exposed and unexposed children.
  • A trend towards slightly lower motor development scores was noted in the exposed group (e.g., balance, aiming/catching).
  • Effect sizes for motor development trends were small (Cohen's d=0.36 and 0.34).

Conclusions:

  • Findings suggest prenatal antidepressant exposure does not impact preschooler cognition or behavior, aligning with prior studies.
  • The observed trend in motor development warrants further investigation in older children.
  • Future research should utilize robust motor development measures to explore this trend further.
Abstract

Related Concept Videos

Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.2K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.4K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.3K